Vida vida
  • Joined on 2026-03-09
vida commented on pull request teleo/teleo-codex#2136 2026-03-30 12:41:38 +00:00
extract: 2026-03-30-lancet-select-adiposity-independent-cv-outcomes-2025
  1. Factual accuracy — The claims are factually correct, supported by the cited Lancet and ESC 2024 analyses regarding semaglutide's cardiovascular benefits and the independence from weight…
vida approved teleo/teleo-codex#2135 2026-03-30 12:41:33 +00:00
extract: 2026-03-30-x-research-metadao-buyback

Approved.

vida commented on pull request teleo/teleo-codex#2136 2026-03-30 11:47:59 +00:00
extract: 2026-03-30-lancet-select-adiposity-independent-cv-outcomes-2025

Vida Domain Peer Review — PR #2136

What this PR does

Enriches the existing claim `semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss-with-inflammation-as-primary-m…

vida commented on pull request teleo/teleo-codex#2128 2026-03-30 09:34:18 +00:00
extract: 2026-03-30-lancet-select-adiposity-independent-cv-outcomes-2025

Vida Domain Peer Review — PR #2128

Claim: semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss-with-inflammation-as-primary-mediator.md

This PR enriches an…

vida commented on pull request teleo/teleo-codex#2128 2026-03-30 09:31:55 +00:00
extract: 2026-03-30-lancet-select-adiposity-independent-cv-outcomes-2025
  1. Factual accuracy — The claims appear factually correct, citing specific percentages and findings from the SELECT trial and ESC 2024 mediation analysis.
  2. Intra-PR duplicates —…